CPIG
TMO icon

Chicago Partners Investment Group’s Thermo Fisher Scientific TMO Stock Holding History

Chicago Partners Investment Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Buy
1,947
+145
+8% +$69.6K 0.02% 602
2026
Q1 		$926K Buy
1,802
+756
+72% +$410K 0.02% 582
2025
Q4 		$655K Buy
1,046
+46
+5% +$26K 0.02% 628
2025
Q3 		$558K Buy
1,000
+119
+14% +$55.4K 0.01% 645
2025
Q2 		$411K Sell
881
-98
-10% -$41K 0.01% 684
2025
Q1 		$399K Buy
979
+134
+16% +$72.6K 0.01% 595
2024
Q4 		$460K Sell
845
-156
-16% -$85.8K 0.02% 526
2024
Q3 		$577K Buy
1,001
+290
+41% +$172K 0.02% 453
2024
Q2 		$437K Sell
711
-44
-6% -$25.2K 0.02% 503
2024
Q1 		$434K Buy
755
+297
+65% +$167K 0.02% 488
2023
Q4 		$247K Sell
458
-146
-24% -$70.7K 0.01% 585
2023
Q3 		$279K Buy
604
+61
+11% +$32.5K 0.02% 527
2023
Q2 		$301K Sell
543
-34
-6% -$18.3K 0.02% 531
2023
Q1 		$331K Buy
577
+94
+19% +$53K 0.02% 488
2022
Q4 		$282K Buy
483
+39
+9% +$20.7K 0.02% 494
2022
Q3 		$219K Buy
444
+55
+14% +$30.8K 0.02% 513
2022
Q2 		$233K Sell
389
-20
-5% -$11K 0.02% 502
2022
Q1 		$222K Buy
409
+32
+8% +$18.4K 0.02% 490
2021
Q4 		$212K Buy
377
+39
+12% +$24.4K 0.02% 513
2021
Q3 		$213K Buy
+338
New +$186K 0.01% 535
2018
Q4 		– Sell
-300
Closed -$69K – 864
2018
Q3 		$69K Hold
300
– – 0.01% 474
2018
Q2 		$62K Sell
300
-121
-29% -$25.7K 0.01% 451
2018
Q1 		$87K Buy
421
+121
+40% +$25.4K 0.01% 369
2017
Q4 		$57K Hold
300
– – 0.01% 431
2017
Q3 		$57K Sell
300
-400
-57% -$72.4K 0.01% 423
2017
Q2 		$108K Buy
+700
New +$118K 0.03% 268
2016
Q1 		– Sell
-893
Closed -$127K – 480
2015
Q4 		$127K Buy
+893
New +$119K 0.06% 203

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Chicago Partners Investment Group's TMO Position: Q2 2026 in Review

Chicago Partners Investment Group increased its Thermo Fisher Scientific (TMO) stake by 8% in Q2 2026, buying an estimated $69.6K and bringing the position to 1,947 shares worth $1.11M. The position accounts for 0.02% of the portfolio, ranked #602.

Chicago Partners Investment Group first reported a position in TMO in Q4 2015 and has held it in 27 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Chicago Partners Investment Group held 1,947 shares of Thermo Fisher Scientific worth $1.11M as of Q2 2026.
  • Chicago Partners Investment Group bought 145 Thermo Fisher Scientific shares in Q2 2026, an estimated $69.6K.
  • Thermo Fisher Scientific made up 0.02% of Chicago Partners Investment Group's portfolio in Q2 2026, its #602 holding.
  • Chicago Partners Investment Group first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 27 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.